Pharmaceuticals China

China Parenteral Nutrition Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

China Parenteral Nutrition Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

China · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $664.7 Mn Placeholder estimate
Estimate 2025 $716.5 Mn 9.1% of the global market
Projected 2034 $1.41 Bn 96.6% Adds $692.1 Mn over 9 forecast years
CAGR 2025–2034 7.8% Faster than 28% of 180 Pharmaceuticals markets here
Key players 5
  • China is 9.11% of the global market.
  • In APAC, the largest is China (this report) at $716.5 Mn.
  • Fastest growing: India at 9% a year.
  • China ranks 1st of 10 by size in APAC.

Market size projection

China

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$692.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Parenteral Nutrition Market market size by year, China
YearMarket sizeChange that yearSince 2025
2024 (estimate) $664.7 Mn — —
2025 (base) $716.5 Mn +$51.8 Mn —
2026 (forecast) $772.4 Mn +$55.9 Mn +7.8%
2027 (forecast) $832.7 Mn +$60.2 Mn +16.2%
2028 (forecast) $897.6 Mn +$64.9 Mn +25.3%
2029 (forecast) $967.6 Mn +$70.0 Mn +35%
2030 (forecast) $1.04 Bn +$75.5 Mn +45.6%
2031 (forecast) $1.12 Bn +$81.4 Mn +56.9%
2032 (forecast) $1.21 Bn +$87.7 Mn +69.2%
2033 (forecast) $1.31 Bn +$94.6 Mn +82.4%
2034 (forecast) $1.41 Bn +$101.9 Mn +96.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $7.87 Bn
  2. North America $3.37 Bn
  3. US $2.83 Bn
  4. APAC $1.79 Bn
  5. Europe $1.55 Bn
  6. China (this report) $716.5 Mn
  7. Canada $546.7 Mn
  8. Japan $447.5 Mn
  9. Latin America $325.5 Mn
  10. Middle East $280.3 Mn
  11. Germany $238.2 Mn
  12. UK $226.2 Mn
  13. France $206.0 Mn
  14. Brazil $180.5 Mn
  15. Italy $171.9 Mn
  16. India $166.5 Mn
  17. Ecuador $153.7 Mn
  18. Saudi Arabia $139.1 Mn
  19. Spain $127.3 Mn
  20. Mexico $126.0 Mn
  21. Africa $123.6 Mn
  22. Australia $93.4 Mn
  23. New Zealand $76.5 Mn
  24. Russia $75.7 Mn
  25. South Africa $57.7 Mn
  26. UAE $35.3 Mn
  27. Egypt $20.5 Mn
  28. Philippines $18.4 Mn
  29. Malaysia $14.0 Mn
  30. Hong Kong $12.0 Mn
  31. Thailand $10.1 Mn
  32. Singapore $8.3 Mn
  33. Kenya $5.0 Mn

Report snapshot

China Parenteral Nutrition Market Analysis at a glance
Market size, 2025$716.5 Mn placeholder estimate
Forecast, 2034$1.41 Bn placeholder estimate
Growth (CAGR), 2025–20347.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, setting and end user (see all)
Key playersFresenius Kabi AG, Baxter International, B. Braun, ICU Medical, Otsuka Pharmaceutical Co., Ltd. (see all)
Regulator in ChinaNMPASource: National Medical Products Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The China Parenteral Nutrition Market Analysis Executive Summary

Parenteral nutrition feeds patients through a vein when they cannot eat or absorb food through the gut.

Key segments of the parenteral Nutrition market include product (Amino Acids, Lipid Emulsions and Carbohydrates) and setting (Hospitals and Home Care).

Bar chart: China Parenteral Nutrition market size, 2024–2034, placeholder estimates. $664.7 Mn in 2024, $716.5 Mn in 2025 and $1.41 Bn in 2034, 7.8% CAGR.
China Parenteral Nutrition market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

China Parenteral Nutrition Market Dynamics

Market Growth Drivers

More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the parenteral Nutrition market.

Opportunity

Ready-to-use formulations, biosimilars and supply security programmes give the parenteral Nutrition market room to grow.

Market Restraints

Drug shortages, price controls, generic competition and strict hospital budgets hold back the parenteral Nutrition market.

Competitive Landscape for Parenteral Nutrition Market in China

The parenteral Nutrition market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Parenteral Nutrition Market in China

Parenteral Nutrition in China: rules and payment

Drugs need approval from the National Medical Products Administration (NMPA) before sale.⁠[1] Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List.⁠[2]

[1] National Medical Products Administration. Checked 14 Nov 2026.

[2] National Healthcare Security Administration. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for parenteral Nutrition. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in China.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Parenteral Nutrition right now, from free public sources.

Latest research 4,884 papers since 2021 (worldwide)

  1. Effect of nasojejunal enteral nutrition support on clinical outcomes and prognosis in elderly patients with severe pneumonia. Nutricion hospitalaria, 2026
  2. [Analysis of the appropriateness and quality of tricameral parenteral nutrition prescriptions in non-critical care inpatients ‒ A prospective study with an educational intervention]. Nutricion hospitalaria, 2026
  3. Beyond enteral feedings: Teduglutide and its role in gut resiliency. JPGN reports, 2026
  4. Development and validation of an early prediction model for intestinal failure-associated liver disease after enterostomy for necrotizing enterocolitis. Pediatric research, 2026
  5. Fatal metabolic acidosis associated with biotin deficiency in extremely preterm infants. The journal of medical investigation : JMI, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Parenteral Nutrition in context

China compared

  • Health spending per person: 763 US$ per person (2023). World: 1,317 US$ per person (2023). 5th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.9% of people (2025). World: 10.4% of people (2025). 6th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Parenteral Nutrition market in China?
Placeholder estimate: about $716.5 Mn in 2025, rising to about $1.41 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Parenteral Nutrition market in China growing?
Placeholder estimate: about 7.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Parenteral Nutrition market report cover?
The report splits the market by product (Amino Acids, Lipid Emulsions, Carbohydrates, Vitamins and Trace Elements), setting (Hospitals, Home Care) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Parenteral Nutrition market?
Key players include Fresenius Kabi AG, Baxter International, B. Braun, ICU Medical and Otsuka Pharmaceutical Co., Ltd..
What is driving the Parenteral Nutrition market?
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the parenteral Nutrition market.
Who regulates Parenteral Nutrition in China?
Drugs need approval from the National Medical Products Administration (NMPA) before sale. Source: National Medical Products Administration. Checked 14 Nov 2026.
How is healthcare paid for in China?
Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List. Source: National Healthcare Security Administration. Checked 14 Nov 2026.
How much research is published on Parenteral Nutrition?
PubMed lists 4,884 papers on Parenteral Nutrition added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Parenteral Nutrition in China? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Bone and Joint Health: Supplements for an Ageing Population1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence… Eye Health Supplements: Screens, Ageing and Vision2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a… Herbal Supplements: Quality, Safety and Trust170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in China

See all
Same topic, other categories

Related on nutrition and hospital

See the topic